JD Health International Inc. (HKG:6618)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
37.74
-0.02 (-0.05%)
Jun 15, 2026, 4:09 PM HKT

JD Health International Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, JD Health International stock has a consensus rating of "Strong Buy" and an average price target of $71.83. The average 1-year stock price forecast is 90.33% higher than the current stock price, while the lowest is $61.25 (+62.29%) and the highest is $94.89 (+151.43%).

Price Target: $71.83 (+90.33%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$61.25$71.83$68.04$94.89
Change+62.29%+90.33%+80.29%+151.43%

Analyst Ratings

The average analyst rating for JD Health International stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy151515141414
Buy223333
Hold221111
Sell000000
Strong Sell000000
Total191919181818

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Citic Securities
No rating
Citic Securities
Buy
Maintains
$74.00
BuyMaintains$74.00+96.08%Jun 3, 2026
Unknown Analyst
Bank of America Securities
No rating
Bank of America Securities
Buy
Maintains
$75.00$68.00
BuyMaintains$75.00$68.00+80.18%May 22, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$66.20
BuyMaintains$66.20+75.41%May 17, 2026
Unknown Analyst
CSC Financial
No rating
CSC Financial
Buy
Maintains
$69.22$58.28
BuyMaintains$69.22$58.28+54.43%May 15, 2026
Unknown Analyst
Goldman Sachs
No rating
Goldman Sachs
Buy
Maintains
$66.00$65.00
BuyMaintains$66.00$65.00+72.23%May 15, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
86.74B
from 73.44B
Increased by 18.11%
Revenue Next Year
100.07B
from 86.74B
Increased by 15.36%
EPS This Year
2.08
from 2.04
Increased by 1.58%
EPS Next Year
2.45
from 2.08
Increased by 18.04%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
30.68B46.74B53.53B58.16B73.44B86.74B
Revenue Growth
58.30%52.32%14.54%8.65%26.28%18.11%
Gross Profit
7.20B9.89B11.87B13.31B18.20B21.96B
Gross Margin
23.46%21.16%22.17%22.88%24.78%25.31%
Operating Income
-1.40B-145.12M630.85M1.16B3.80B5.12B
Net Income
-1.07B380.11M2.14B4.16B5.38B5.79B
EPS
----2.042.08
EPS Growth
----34.79%1.58%
Forward PE
112.3267.4026.4117.6024.3715.71
Free Cash Flow
3.22B3.16B2.75B2.35B7.24B7.70B
No. Analysts
-----18
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High88.2B
Avg86.7B
Low84.8B

Revenue Growth

Revenue Growth202620272028
High
20.1%
Avg
18.1%
Low
15.5%

EPS Forecast

EPS202620272028
High2.32
Avg2.08
Low1.78

EPS Growth

EPS Growth202620272028
High
13.5%
Avg
1.6%
Low
-12.9%